Haleon and Singapore's Agency for Science, Technology…

The study on Centrum will further establish the role of multivitamin and mineral (MVM) supplementation on metabolic health among middle-aged Asian women, who are often under-represented in global research. Metabolic health issues are an increasing concern globally and across Asia, driven by ageing populations.

Women in midlife experience unique physiological changes associated with menopausal transition, which may increase vulnerability to metabolic syndrome.[3] Metabolic syndrome refers to a cluster of risk factors, such as higher blood pressure, unhealthy cholesterol levels, and poorer blood sugar control. Metabolic syndrome significantly raises.

What Happened

Supporting women's health during this life stage is critical not only for individual well-being, but also for families, communities and economies. "As more people are diagnosed with conditions linked to metabolic health, we are strengthening our focus on prevention and healthy ageing.

• While women tend to live longer than men, data suggests that they also spend 25% more of their lives in poorer health[2].

• The World Economic Forum has estimated that every US$1 invested in women's health can generate up to US$3 in economic returns through improved productivity and reduced healthcare costs[4].

• The Haleon–ASTAR IHDP partnership reflects a shared ambition to bridge scientific research and practical health solutions, supporting preventive health approaches that empower individuals to take charge of their own health.

Key Details

This collaboration reflects ASTAR's commitment to research that supports healthier lives and human potential in Singapore.

What Reports Say

Coverage of the story so far points to:

• Continued reporting by aapnews.aap.com.au as more details emerge